The research conducted in the EURIDOL laboratories is supported by a variety of funding sources: institutions, private sector, foundations, associations...
Summary
Funding via the University of Strasbourg Foundation
In support of the Strasbourg Pain Initiative, pain research was designated as one of 12 priority projects of the "Tous Nobels!" Campaign, carried by the University of Strasbourg Foundation. This ongoing fundraising campaign already led to the consortium's first financial supports:
The Roche Fund for personalised medicine research supported 4 research teams from the Strasbourg Pain Initiative through a call for projects. The supported projects focus on:
the study of GRP10 as a new target for the treatment of pain
the action of antidepressants on the emotional component of pain
the establishment and evaluation of nociception in very premature newborns
the evaluation and improvement of the diagnosis of diabetic neuropathies in the elderly.
The Boiron company supports a EURIDOL thesis project on low dose opiates and cannabinoids in neuropathic pain.
Institutional Co-financing
EURIDOL research teams also benefit from several institutional supports.
2 examples are displayed hereafter:
The Grand Est Region
currently co-finances 2 theses projects with up to 100,000 euros each.
supports functional exploration platforms with 620,000 Euros, aimed at structuring pain research in the Grand Est Region (CLueDol).
The European Union
supports "HaPpY", a European Joint Doctoral Training Programme on comorbidities of chronic pain and mood disorders with 3.9 million Euros. HaPpY is led by a EURIDOL team leader and allows the funding of 15 doctoral fellowships, including 7 EURIDOL doctoral students enrolled at the University of Strasbourg.
